Eric Durbin, DrPH, MS

  • Director, Kentucky Cancer Registry
  • Director, Cancer Research Informatics Shared Resource Facility


Faculty Rank

  • Assistant Professor of Biomedical Informatics

Training & Education


Public Health, University of Kentucky


Research Focus

Electronic cancer surveillance; natural language processing of free-text health records; cancer epidemiology; population/public health informatics.

Contact Information

2365 Harrodsburg Road
Suite A230
Lexington, KY 40504
United States



  1. The Effect of Insurance on Stage at Diagnosis for Colorectal Cancer Patients in Kentucky.
    Tucker TC, Huang B, Benett J, Durbin EB, Jones W. J Kentucky Medical Association 2011.
  2. Geographic Patterns in Lung Cancer Incidence and Mortality in Utah: 1997-2006
    Stroup AM, Durbin EB, Harrell, CJ, et al. Utah’s Health: An Annual Review. 2010.
  3. Effect of α1-Adrenoceptor Antagonist Exposure on Prostate Cancer Incidence: An Observation Cohort Study.
    Harris AM, Warner BW, Wilson JM, Becker A, Rowland RG, Conner W, Lane M, Kimbler K, Durbin EB, Baron AT, Kyprianou N. J Urol 178(5):2176-80, 2007.
  4. Central Cancer Registries Design, Management and Use.
    Durbin EB. Computer Resources. In Menck, HR, Deapen, D, Phillips, JL, Tucker, TC (Eds.) Central Cancer Registries Design, Management and Use. 2007.
  5. Automated Coding of Key Cancer Concepts from Text Based Electronic Pathology Reports.
    Durbin EB, Gal T, Cernile G, Johnson TR. AMIA Summit on Translational Bioinformatics Proceedings. 2012 March 19; 2012:137.
  6. Automatic Extraction of ICD-O-3 Primary Sites from Cancer Pathology Reports.
    Kavuluru R, Hands I, Durbin EB, Witt L. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science. 2013; 2013:112-6. PubMed [journal] PMID: 24303247, PMCID: PMC3845766.
  7. Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.
    Chen L, Voronovich Z, Clark K, Hands I, Mannas J, Walsh M, Nikiforova MN, Durbin EB, Weiss H, Horbinski C. Neuro-oncology. 2014; 16(11):1478-83. PubMed [journal] PMID: 24860178, PMCID: PMC4201069.
  8. Incidence of brain metastasis at initial presentation of lung cancer.
    Villano JL, Durbin EB, Normandeau C, Thakkar JP, Moirangthem V, Davis FG. Neuro-oncology. 2015; 17(1):122-8. PubMed [journal] PMID: 24891450, PMCID: PMC4483041.
  9. Nodal Upstaging During Lung Cancer Resection Is Associated With Surgical Approach.
    Martin JT, Durbin EB, Chen L, Gal T, Mahan A, Ferraris V, Zwischenberger J. The Annals of thoracic surgery. 2016/01; 101(1):238-44; discussion 44-5. NIHMSID: NIHMS705710 PubMed [journal] PMID: 26428690, PMCID: PMC4689653.
  10. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.
    Stewart RL, Carpenter BL, West DS, Knifley T, Liu L, Wang C, Weiss HL, Gal TS, Durbin EB, Arnold SM, O'Connor KL, Chen M. Oncotarget. 2016/04; 7(23):34630-42. PubMed [journal] PMID: 27127879, PMCID: PMC5085181.
  11. Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.
    Saeed H, Hnoosh D, Huang B, Durbin EB, McGrath PC, Desimone P, Maynard E, Anthony LB, Dineen SP, Hosein PJ, Tzeng CW. Journal of surgical oncology. 2016/05; 114(4):451-5. PubMed [journal] PMID: 27238300.
  12. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
    Stewart RL, West D, Wang C, Weiss HL, Gal T, Durbin EB, O'Connor W, Chen M, O'Connor KL. Human pathology. 2016/08; 54:174-83. NIHMSID: NIHMS780528 PubMed [journal] PMID: 27107458, PMCID: PMC4938774.
  13. Incidence of CNS tumors in Appalachian children.
    Huang B, Luo A, Durbin EB, Lycan E, Tucker T, Chen Q, Horbinski C, Villano JL. Journal of neuro-oncology. 2017; PubMed [journal] PMID: 28285334, PMCID: PMC5481463.
  14. Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer.
    Le A-T, Huang B, Hnoosh D, Saeed H, Dineen SP, Hosein PJ, Durbin EB, Kudrimoti M, McGrath PC and Tzeng C-WD. Journal of Surgical Research 214:1-8, 2017.
  15. Global burden of neuroendocrine tumors and changing incidence in Kentucky.
    Chauhan A, Yu Q, Ray N, Farooqui Z, Huang B, Durbin EB, Tucker T, Evers M, Arnold S, Anthony LB. Oncotarget. 2018 Apr 10;9(27):19245-19254. doi: 10.18632/oncotarget.24983. eCollection 2018 Apr 10. PubMed PMID: 29721198; PubMed Central PMCID: PMC5922392.
  16. Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
    McKenna MK, Noothi SK, Alhakeem SS, Oben KZ, Greene JT, Mani R, Perry KL, Collard JP, Rivas JR, Hildebrandt GC, Fleischman RA, Durbin EB, Byrd JC, Wang C, Muthusamy N, Rangnekar VM, Bondada S. Blood. 2018 Jun 28;131(26):2943-2954. doi: 10.1182/blood-2017-10-813931. Epub 2018 Apr 25. PubMed PMID: 29695515; PubMed Central PMCID: PMC6024641.
  17. Late-Stage Melanoma: Be Sure to Screen Uninsured, Unmarried Men.
    Valentin VL, Sanderson W, Westneat S, Durbin E. South Med J. 2018 Nov;111(11):649-653. doi: 10.14423/SMJ.0000000000000888. PubMed PMID: 30391998.
  18. Spatiotemporal Analysis of Lung Cancer Histological Types in Kentucky, 1995-2014.
    Christian WJ, Vanderford NL, McDowell J, Huang B, Durbin EB, Absher KJ, Walker CJ, Arnold SM. Cancer Control. 2019 Jan-Dec;26(1):1073274819845873. doi: 10.1177/1073274819845873. PubMed PMID: 31014079; PubMed Central PMCID: PMC6482657.
  19. Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky.
    Liu J, Murali T, Yu T, Liu C, Sivakumaran TA, Moseley HNB, Zhulin IB, Weiss HL, Durbin EB, Ellingson SR, Liu J, Huang B, Hallahan BJ, Horbinski CM, Hodges K, Napier DL, Bocklage T, Mueller J, Vanderford NL, Fardo DW, Wang C, Arnold SM. Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):348-356. doi: 10.1158/1055-9965.EPI-17-0984. Epub 2018 Oct 30. PubMed PMID: 30377206; PubMed Central PMCID: PMC6363884.
  20. A case-control study of trace-element status and lung cancer in Appalachian Kentucky.
    Unrine JM, Slone SA, Sanderson W, Johnson N, Durbin EB, Shrestha S, Hahn EJ, Feltner F, Huang B, Christian WJ, Mellon I, Orren DK, Arnold SM. PLoS One. 2019 Feb 27;14(2):e0212340. doi: 10.1371/journal.pone.0212340. eCollection 2019. PubMed PMID: 30811496.
  21. Validity of Natural Language Processing for Ascertainment of EGFR and ALK Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.
    Goulart BHL, Silgard ET, Baik CS, Bansal A, Sun Q, Durbin EB, Hands I, Shah D, Arnold SM, Ramsey SD, Kavuluru R, Schwartz SM. JCO Clin Cancer Inform. 2019 May;3:1-15. doi: 10.1200/CCI.18.00098. PubMed PMID: 31058542.
  22. Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers.
    Gallaway MS, Huang B, Chen Q, Tucker TC, McDowell JK, Durbin E, Stewart SL, Tai E. J Community Health. 2019 Jun;44(3):552-560. doi: 10.1007/s10900-019-00622-z. PubMed PMID: 30767102; PubMed Central PMCID: PMC6504566.
  23. Unlocking the potential of population-based cancer registries.
    Tucker TC, Durbin EB, McDowell JK, Huang B. Cancer. 2019 Aug 5;. doi: 10.1002/cncr.32355. [Epub ahead of print] Review. PubMed PMID: 31381143.
  24. Cross-registry neural domain adaptation to extract mutational test results from pathology reports.
    Rios A, Durbin EB, Hands I, Arnold SM, Shah D, Schwartz SM, Goulart BHL, Kavuluru R. J Biomed Inform. 2019 Sep;97:103267. doi: 10.1016/j.jbi.2019.103267. Epub 2019 Aug 8. PubMed PMID: 31401235; PubMed Central PMCID: PMC6736690.